Public Services Division
Drug Industry, New Drugs in Development, and Clinical Trials
Center for Biologics Evaluation and Research (CBER) is the Center within FDA that regulates biological products for human use under applicable federal laws, including the Public Health Service Act and the Federal Food, Drug and Cosmetic Act.
Center for Drug Evaluation and Research (CDER) of the FDA- U.S. Food and Drug Administration performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. It regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs, and other products such as toothpastes, antiperspirants, shampoos and sunscreens.
International Federation of Pharmaceutical Manufacturers and Associations is a global, non-profit, nongovernmental organization with members across the globe based in Geneva, Switzerland, representing the research-based pharmaceutical industry, including the biotechnology and vaccine sectors.
Pharmaceutical Research and Manufacturers of America (PhRMA). Represents U.S. pharmaceutical industry research and biotechnology companies. Publishes fact sheets, white papers and other publications that include statistical information.
Society for Clinical Trials is international professional organization dedicated to the development and dissemination of knowledge about the design, conduct and analysis of government and industry-sponsored clinical trials and related health care research methodologies.
The Tufts Center for the Study of Drug Development (Tufts CSDD) of Tufts University is an independent, academic, non-profit research group internationally recognized for its scholarly analyses and thoughtful commentary on pharmaceutical issues.